Sponsored by:

Molecular Imaging: Page 109

AuntMinnie.com Molecular Imaging Insider
By Brian Casey
November 17, 2020
Spectrum Dynamics nabs Vizient contract for SPECT/CT
By AuntMinnie.com staff writers
Molecular imaging technology developer Spectrum Dynamics has received a pediatric program contract from the group purchasing organization Vizient. Spectrum will provide its Veriton-CT digital SPECT/CT to Vizient's customer base
November 12, 2020
2020 01 08 19 05 8090 Business Hands 400
Sofie, Lantheus ink deal for prostate cancer imaging agent
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has signed a commercial supply agreement with Lantheus Holdings, parent company of Lantheus Medical Imaging, to manufacture and distribute Lantheus' lead investigational prostate cancer imaging agent, PyL.
November 12, 2020
2020 07 28 23 23 5650 Business Hands Cooperation 400
FDA clears Lantheus' AI bone software
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Lantheus Holdings, parent company of Lantheus Medical Imaging, for its artificial intelligence (AI)-enabled automated bone scan index software on GE Healthcare's Xeleris nuclear medicine workstation.
November 12, 2020
2019 10 17 18 08 9848 Computer Doctor Virtual 400
Nuclear medicine groups oppose Humana PET/CT policy
By AuntMinnie.com staff writers
Groups that represent nuclear medicine physicians have voiced their opposition to a decision by Humana to not widely reimburse for PET/CT procedures performed for myocardial perfusion.
November 11, 2020
2020 11 12 20 49 4516 Heart Hologram Virtual 400
Tau Alzheimer's blood test gives PET a run for its money
By Emily Hayes
Blood tests that detect a biomarker for abnormal tau metabolism in the brain were able to detect pathology earlier than PET scans in patients with preclinical Alzheimer's disease in a study reported online November 9 in JAMA Neurology.
November 9, 2020
2020 11 10 17 47 8391 Brain Puzzle Stars 400
Coding and documentation for Y-90 radioembolization
By Erin Stephens
The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Erin Stephens of Healthcare Administrative Partners describes how to overcome them.
November 8, 2020
2018 10 18 23 20 1387 Liver Cancer 400
Isotopia partners with Y-mAbs on radioisotope
By AuntMinnie.com staff writers
Isotopia Molecular Imaging is collaborating with biopharmaceutical company Y-mAbs Therapeutics for the supply of the medical radioisotope no-carrier-added lutetium-177.
November 5, 2020
2019 10 25 00 49 3370 Hands Shaking2 400
Lantheus reports mixed Q3 results
By AuntMinnie.com staff writers
Lantheus Holdings, parent company of Lantheus Medical Imaging, has released mixed results for its third quarter.
November 4, 2020
2020 02 06 18 18 1550 Business Financial Results 400
Shine makes 1st commercial sales of Lu-177
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies made its first commercial sales of its lutetium-177 (Lu-177) therapeutic isotope to multiple customers.
November 3, 2020
2018 04 24 20 24 4264 Isotope 400
Jubilant inks deal to invest $25M in Sofie
By AuntMinnie.com staff writers
Jubilant Radiopharma will invest $25 million into molecular imaging developer Sofie Biosciences under a new partnership agreement.
November 3, 2020
2020 11 04 18 50 6655 Business Intelligence 400
Digirad to sell mobile imaging division
By AuntMinnie.com staff writers
Nuclear medicine equipment and services firm Digirad has entered into an agreement to sell its mobile imaging division DMS Health Technologies to Knob Creek Acquisition of Tennessee for $18.8 million.
November 3, 2020
2016 09 14 15 25 23 643 Dollar Sign 400
Previous Page
Page 109 of 614
Next Page